CoChat

Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes

Open access

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Currently there is debate on whether hypoglycemia is an independent risk factor for atherosclerosis, but little attention has been paid to the effects of recovery from hypoglycemia. In normal control individuals and in people with type 1 diabetes, recovery from a 2-h induced hypoglycemia was obtained by reaching normoglycemia or hyperglycemia for another 2 h and then maintaining normal glycemia for the following 6 h. Hyperglycemia after hypoglycemia was also repeated with the concomitant infusion of vitamin C. Recovery with normoglycemia is accompanied by a significant improvement in endothelial dysfunction, oxidative stress, and inflammation, which are affected by hypoglycemia; however, a period of hyperglycemia after hypoglycemia worsens all of these parameters, an effect that persists even after the additional 6 h of normoglycemia. This effect is partially counterbalanced when hyperglycemia after hypoglycemia is accompanied by the simultaneous infusion of vitamin C, suggesting that when hyperglycemia follows hypoglycemia, an ischemia–reperfusion-like effect is produced. This study shows that the way in which recovery from hypoglycemia takes place in people with type 1 diabetes could play an important role in favoring the appearance of endothelial dysfunction, oxidative stress, and inflammation, widely recognized cardiovascular risk factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db12-0224

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Levels for glucose, sICAM-1, FMD, nitrotyrosine, IL-6, and 8-iso-PGF2α in type 1 diabetes are shown for hypoglycemia + hyperglycemia (solid line), hypoglycemia + normoglycemia (dashed line), and hypoglycemia + hyperglycemia + vitamin C (dashed-dotted line). *P < 0.05 vs. basal. #P < 0.01 vs. basal. §P < 0.01 vs. hypoglycemia + normoglycemia. “P < 0.05 vs. hypoglycemia + normoglycemia. P < 0.01 vs. hypoglycemia + hyperglycemia + vitamin C.
FIG. 1. Levels for glucose, sICAM-1, FMD, nitrotyrosine, IL-6, and 8-iso-PGF2α in type 1 diabetes are shown for hypoglycemia + hyperglycemia (solid line), hypoglycemia + normoglycemia (dashed line), and hypoglycemia + hyperglycemia + vitamin C (dashed-dotted line). *P < 0.05 vs. basal. #P < 0.01 vs. basal. §P < 0.01 vs. hypoglycemia + normoglycemia. “P < 0.05 vs. hypoglycemia + normoglycemia. P < 0.01 vs. hypoglycemia + hyperglycemia + vitamin C.CC BY-NC-ND · PubMed Central
FIG. 2. Levels for glucose, sICAM-1, FMD, nitrotyrosine, IL-6, and 8-iso-PGF2α in normal healthy control subjects are shown for hypoglycemia + hyperglycemia (solid line), hypoglycemia + normoglycemia (dashed line), and hypoglycemia + hyperglycemia + vitamin C (dashed-dotted line). *P < 0.05 vs. basal. #P < 0.01 vs. basal. §P < 0.01 vs. hypoglycemia + normoglycemia. P < 0.01 vs. hypoglycemia + hyperglycemia + vitamin C.
FIG. 2. Levels for glucose, sICAM-1, FMD, nitrotyrosine, IL-6, and 8-iso-PGF2α in normal healthy control subjects are shown for hypoglycemia + hyperglycemia (solid line), hypoglycemia + normoglycemia (dashed line), and hypoglycemia + hyperglycemia + vitamin C (dashed-dotted line). *P < 0.05 vs. basal. #P < 0.01 vs. basal. §P < 0.01 vs. hypoglycemia + normoglycemia. P < 0.01 vs. hypoglycemia + hyperglycemia + vitamin C.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 156

Metadata

Authors
Ceriello, A., Novials, A., Ortega, E., La Sala, L., Pujadas, G., Testa, R., Bonfigli, A. R., Esposito, K., & Giugliano, D.
Affiliations
  • Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas (ES)
  • Department of Endocrinology, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
  • Hospital Clínic de Barcelona (ES)
  • Istituto Nazionale di Riposo e Cura per Anziani (IT)
  • University of Campania "Luigi Vanvitelli" (IT)
Corresponding author
Ceriello, Antonio
Venue
Diabetes
Published
2012-10-16
Volume
61
Issue
11
Pages
2993-2997
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2107614741
Cited by
155
References
25
Citations by year
2026: 2 · 2025: 6 · 2024: 6 · 2023: 11 · 2022: 9 · 2021: 16 · 2020: 17 · 2019: 14 · 2018: 12 · 2017: 10 · 2016: 14 · 2015: 12 · 2014: 14 · 2013: 9 · 2012: 2
FWCI
9.50
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
hypoglycemia, hyperglycemia, endothelial dysfunction, oxidative stress, inflammation, type 1 diabetes, vitamin C, ischemia-reperfusion, atherosclerosis risk, cardiovascular risk factors
MeSH terms
Adult, Antioxidants, Ascorbic Acid, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Endothelium, Vascular, Female, Glucose, Humans, Hyperglycemia, Hypoglycemia, Hypoglycemic Agents, Infusions, Intravenous, Insulin, Male, Risk Factors, Vasodilation, Oxidative Stress, Cross-Over Studies, Inflammation Mediators, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes. https://app.cochat.ai/papers/10.2337/db12-0224
The paper
Ceriello, A., Novials, A., Ortega, E., La Sala, L., Pujadas, G., Testa, R., Bonfigli, A. R., Esposito, K., & Giugliano, D. (2012). Evidence That Hyperglycemia After Recovery From Hypoglycemia Worsens Endothelial Function and Increases Oxidative Stress and Inflammation in Healthy Control Subjects and Subjects With Type 1 Diabetes. Diabetes. https://doi.org/10.2337/db12-0224

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.